Brief Article
Copyright ©2010 Baishideng Publishing Group Co.
World J Gastroenterol. Nov 14, 2010; 16(42): 5342-5346
Published online Nov 14, 2010. doi: 10.3748/wjg.v16.i42.5342
Figure 2
Figure 2 Improvement of abdominal symptoms was evaluated using gastrointestinal symptom rating scale scores. The scores were not significantly reduced after treatment as compared with before treatment in both proton pump inhibitors (PPI) and histamine 2 receptor antagonists (H2RA) groups. aNS vs before. NS: Not significant.